Trial Profile
A phase III, randomized, parallel group, open study to compare the therapeutic efficacy and safety of SMB BUDESONIDE-SALMETEROL DPI capsule 150/25microg BID delivered by the AXAHALER versus SYMBICORT TURBUHALER 200/12microg BID over 12 weeks in moderate to severe persistent asthmatic patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2011
Price :
$35
*
At a glance
- Drugs Budesonide/salmeterol (Primary) ; Budesonide; Budesonide/formoterol
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Laboratoires SMB
- 30 Jul 2011 New trial record